Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Delinia
400 Technology Square, 10th Floor
Cambridge, MA 02139
https://deliniabio.com

Delinia was founded to discover and develop novel therapeutics for the treatment of autoimmune and inflammatory diseases. Delinia's lead program is a molecule that selectively potentiates and expands regulatory T cells (Tregs), the powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Delinia's scientific founders and experienced executive leaders are working to advance the company's initial programs to the clinic. Delinia is headquartered in Cambridge, Massachusetts with research operations in San Francisco, California.

Key Contact
Name
Saurabh Saha
Title
CEO
Funding Events

Date
Amount
Type
Investors
09/14/16 $35,000,000 Series A Atlas Venture
Sofinnova Partners